Artificial Intelligence- and Physician-Interpreted Stool Image Characteristics Correlate with C-Reactive Protein Among Inpatients with Acute Severe Ulcerative Colitis: A Pilot Study

2024-8-26

Clinical course of bio naive ulcerative colitis patients five years after initiation of adalimumab in a nationwide cohort

2024-8-21

A Comparative Analysis of Clinical Symptoms and Modified Pouchitis Disease Activity Index Among Endoscopic Phenotypes of the J pouch in Patients with Inflammatory Bowel Disease

2024-8-2

Applying Machine Learning Models Derived from Administrative Claims Data to Predict Medication Non-Adherence in Patients Self-Administering Biologic Medications for Inflammatory Bowel Disease

2024-7-8

Treatment Pathways in Patients With Crohn’s Disease and Ulcerative Colitis: Understanding the Road to Advanced Therapy

2024-7-1

Patient-Related Factors Associated With Long-Term Outcomes After Successful Endoscopic Balloon Dilation For Crohn’s Disease-Associated Ileo-Colic Strictures: A Systematic Review And Meta-Analysis

2024-7-1

CC360 Pearl: How to Review a Manuscript

2024-7-1

Young Adult Patient and Caregiver Perspectives on Transition Readiness in an Inflammatory Bowel Disease Clinic

2024-7-1

Burden of Bowel Urgency in Patients with Ulcerative Colitis and Crohn’s Disease: A Real-World Global Study

2024-7-1

Does Timing of Ileal Pouch-Anal Anastomosis Matter in Patients with Primary Sclerosing Cholangitis and Orthotopic Liver Transplantation? A Systematic Review and Meta-analysis

2024-6-21

Successful Preoperative Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Portal Decompression in Patients with Inflammatory Bowel Disease and Cirrhosis Requiring Surgical Intervention

2024-6-19

Who should consider IBD fellowship?

2024-5-14

Post-hospitalization short versus long steroid taper strategies in patients with acute severe ulcerative colitis; a comparison of clinical outcomes

2024-4-27

Economics of Emergency Department Visits by Patients with Inflammatory Bowel Disease: A Real-World Analysis

2024-4-26

Strategies for enhancing Inflammatory Bowel Disease care in Pakistan: Bridging gaps and building capacities

2024-4-1

Differences between the 2016 and 2022 FDA guidance – implications for design and interpretation of clinical trials in ulcerative colitis

2024-4-1

Comparing the Effects of Anti-TNF Agent and Ustekinumab on Small Bowel Inflammation in Crohn’s Disease: Inverse Probability Weighting with Stabilized Weights of Propensity Scores

2024-4-1

Racial and Ethnic Disparities in Health-related Outcomes in Crohn’s Disease: Results from the National Health and Wellness Survey

2024-4-1

Remote Between Visit Monitoring in Inflammatory Bowel Disease Care: A Qualitative Study of CAPTURE-IBD Participants and Care Team Members

2024-4-1

Cannabis use in patients with inflammatory bowel disease following legalization of Cannabis in Canada

2024-4-1

Correction to: Risk of Primary Gastrointestinal Lymphoma in Patients With Inflammatory Conditions Exposed to Tumor Necrosis Factor Alpha Inhibitors and Immunomodulators: A Case–Control Study

2024-4-1

Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study

2024-4-1

Effectiveness and persistency of ustekinumab treatment for ulcerative colitis: a Phoenix retrospective cohort study

2024-4-1

Real-World Patterns and Economic Burden Associated with Treatment Failure with Advanced Therapies in Patients with Moderate-to-Severe Ulcerative Colitis

2024-4-1

Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE

2024-4-1

Radiomics-based Analysis of Intestinal Ultrasound Images for Inflammatory Bowel Disease: A Feasibility Study

2024-4-1

Safety and Effectiveness of Ustekinumab for Crohn’s disease with Perianal manifestations: ad-hoc analysis data from 1-year post-marketing surveillance study in Japan

2024-4-1

Longer Colonoscopy Withdrawal Time Is Associated With The Detection Of Visible Dysplasia In Patients With Inflammatory Bowel Disease

2024-3-23

Hyperbaric Oxygen Enabled a Transition to Oral Steroids in an Acute Severe Ulcerative Colitis Flare

2024-3-22

Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study Participants

2024-3-13

Cytomegalovirus Colitis in a Patient with Severe Treatment Refractory Ulcerative Colitis

2024-2-28

Dietary magnesium intake is inversely associated with ulcerative colitis: a case-control study

2024-2-21

Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis

2024-1-20

Comparison of endoscopic and artificial intelligence diagnoses for predicting the histological healing of ulcerative colitis in a real-world clinical setting

2024-1-20

Normal infant immunologic assessment and uneventful live rotavirus vaccination despite continuous tofacitinib exposure in-utero and during breastfeeding

2024-1-20

Effectiveness Of Partial Enteral Nutrition As Add-On To Biologics In Patients With Refractory And Difficult To Treat Crohn’s Disease: A Pilot Study

2024-1-1

Environmental exposure to trace elements and heavy metals preceding the clinical onset of inflammatory bowel disease

2024-1-1

Formylated Peptide Receptor-1 (FPR1) mediated gut inflammation as a therapeutic target in Inflammatory Bowel Disease

2024-1-1

Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study

2024-1-1

Perceptions towards established and novel dietary therapies for Crohn’s disease management among adult patients: results from a questionnaire survey

2024-1-1

Risk of Primary Gastrointestinal Lymphoma in Patients With Inflammatory Conditions Exposed to Tumor Necrosis Factor Alpha Inhibitors and Immunomodulators: A Case–Control Study

2024-1-1

Patient Perceptions of Dietary Therapies in Crohn’s Disease: A Dietitian’s Perspective

2024-1-1

Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies

2024-1-1

American Gastroenterological Association-Proposed Fecal Calprotectin Cutoff of 50 ug/g is Associated With Endoscopic Recurrence in a Real-World Cohort of Patients With Crohn’s Disease Post-ileocolic Resection

2024-1-1

Improved Outcomes Associated with Teduglutide Use in Patients with Both Short Bowel Syndrome and Crohn's Disease

2024-1-1

Crohn's & Colitis 360 Editorial Fellowship: The Inaugural Fellow’s Insights

2024-1-1

Patient and Caregiver Perspectives on their Experiences with Crohn’s Perianal Fistulas

2024-1-1

Evaluation of Factors Contributing to Diagnosis of Crohn’s Disease in the Face of Increasing Trend in Pakistan

2024-1-1

Discordance Between IBD Specialists and Insurance Authorization Denials – A Survey of Specific IBD Treatment Scenarios

2023-12-30

The comorbidity of patient-reported Crohn’s disease activity and depression: the role of health behavior mediators

2023-12-23